KERAFAST, INC. Non-Antibody Products — page 15 of 15
Non-Antibody Products
Page 15 of 15
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Turkey F Cell Line; 16 Weeks PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4018-FP | More Info |
| Turkey RBC2 Cell Line; 1-Day PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4009-FP | More Info |
| Turkey RBC2 Cell Line; 7-Days PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4010-FP | More Info |
| Turkey RBC2 Cell Line; 16 Weeks PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4014-FP | More Info |
| Turkey RBC2 Cell Line; 2 Weeks PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4011-FP | More Info |
| Turkey RBC2 Cell Line; 35 Weeks PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4015-FP | More Info |
| Turkey RBC2 Cell Line; 4 Weeks PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4012-FP | More Info |
| Turkey RBC2 Cell Line; 7 Weeks PH, p2 | Source: Skeletal muscle (pectoralis major). Cell type: Skeletal muscle cel… | 1 vial | EF4013-FP | More Info |
| U-251 MG Glioblastoma Cell Line | Source: Human Brain. Cell type: Glioblastoma. | 1 vial | EDK001 | More Info |
| UNG Null/Lambda-LIZ Transgene Transformed MEF Cell Line (207TAg) | Source: Mouse embryo. Cell type: Transformed MEF. | 1 vial | ENH121-FP | More Info |
| UNG Null/Lambda-LIZ Transgene Transformed MEF Cell Line (210TAg) | Source: Mouse embryo. Cell type: Transformed MEF. | 1 vial | ENH122-FP | More Info |
| U2OS-LacO-I-SceI-TetO Cell Line | Source: Human. Cell type: Bone Osteosarcoma. | 1 vial | ENH105-FP | More Info |
| UV Cleavable Biotin-Alkyne | Synthetic. MW: 736.87 | 10mg | EVU104 | More Info |
| UV Cleavable Biotin-Azide | Synthetic. MW: 781.92 | 10mg | EVU102 | More Info |
| Uveal Melanoma Cell Line (MEL202) | Source: Human Established from a primary eye uveal melanoma. Cell type: Uv… | 1 vial | EEE003 | More Info |
| Uveal Melanoma Cell Line (UPMM-1) | Source: Human Uveal Melanoma. | 1 vial | EDE001 | More Info |
| Uveal Melanoma Cell Line (UPMM-2) | Source: Human Uveal Melanoma. | 1 vial | EDE002 | More Info |
| Wild-type Beta-pol/Lambda-LIZ Transgene Transformed MEF Cell Line (92TAg) | Source: Mouse embryos. Cell type: Transformed MEF. | 1 vial | ENH115-FP | More Info |
| Wild-Type PA (Anthrax Protective Antigen (PA)) | Purified by: Hydroxyapatite Chromatography. | 100ug (7.26mg/mL) | ENH003-LT | More Info |
| Xenopus Carcass Fibroblast Cell Line (XTC-2) | Source: Xenopus laevis. Cell type: Fibroblast. | 1 vial | EMU039 | More Info |
| Xenopus Carcass Fibroblast Cell Line (XTC-2[BirAV5-FLBIO-xKLF9]) | Source: Xenopus laevis. Cell type: Fibroblast. | 1 vial | EMU041 | More Info |
| Xenopus Carcass Fibroblast Cell Line (XTC-2[pEF-BirAV5]) | Source: Xenopus laevis. Cell type: Fibroblast. | 1 vial | EMU040 | More Info |
| Xenopus Cell Line (XL-177) | Source: Xenopus laevis. | 1 vial | EMU036 | More Info |
| Xenopus Cell Line (XL-58) | Source: Xenopus laevis. Cell type: Embryo. | 1 vial | EMU038 | More Info |
| Xenopus Kidney Cell Line (A6) | Source: Xenopus laevis. Cell type: Kidney. | 1 vial | EMU037 | More Info |
| Xenopus Tadpole Tail Myoblast Cell Line (XLT-15) | Source: Xenopus laevis. Cell type: Fibroblast. | 1 vial | EMU035 | More Info |
| Yeast-Display Nanobody Library (NbLib) | Source: S. cerevisiae. | 2 vials (>2.5x10^9 cells) | EF0014-FP | More Info |
| Z-Cy2 Maleimide | Purity: 95 % (NMR, HPLC). MW: 869 | 8nmol | EMT004 | More Info |
| Z-Cy3 Maleimide | Purity: 95 % (NMR, HPLC). MW: 901.1 | 8nmol | EMT005 | More Info |
| Z-Cy5 Maleimide | Purity: 95 % (NMR, HPLC). MW: 899.1 | 8nmol | EMT006 | More Info |
| Z-Cy2 NHS Ester | Purity: 95 % (NMR, HPLC). MW: 985 | 8nmol | EMT001 | More Info |
| Z-Cy3 NHS Ester | Purity: 95 % (NMR, HPLC). MW: 1017.2 | 8nmol | EMT002 | More Info |
| Z-Cy5 NHS Ester | Purity: 95 % (NMR, HPLC). MW: 1015.2 | 8nmol | EMT003 | More Info |
| Z-Cy2 Thiol | Purity: 95 % (NMR, HPLC). MW: 761.9 | 10nmol | EMT007 | More Info |
| Z-Cy3 Thiol | Purity: 95 % (NMR, HPLC). MW: 794.1 | 10nmol | EMT008 | More Info |
| Z-Cy5 Thiol | Purity: 95 % (NMR, HPLC). MW: 792.1 | 10nmol | EMT009 | More Info |
| Z-Rhodamine-SH | Purity: 95 % (NMR, HPLC). MW: 948.21 | 40ug (42nmol) | EMT025 | More Info |
| Zymostenol | Synthetic. Purity: >95%, NMR. MW: 386.66 | 1mg | EVU130 | More Info |
| Zymostenol (d7 isotope) | Synthetic. Purity: >95%, NMR. MW: 393.71 | 1mg | EVU131 | More Info |
KERAFAST, INC.
KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826
info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com
https://www.kerafast.com
Return to Profile